Treatment of unacceptable bleeding in long-term users of 52-mg levonorgestrel intrauterine device: a prospective observational studyAJOG Global Reports at a Glance by Patty A.H.H. van der Heijden, MD, Karlijn A. Röttgering, Tamara J. Oderkerk, MD, Jeanne P. Dieleman, Arianne C. Lim, PhD, Marlies Y. Bongers, PhD, Peggy M.A.J. Geomini, PhD

Get full text